IRVINE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial ...

Sales of Beta Bionics insulin pumps spiked 145% in the fourth quarter behind solid new patient starts. Elsewhere, former Masimo exec Jon Coleman joined Dexcom, and Sibionics’ CGM earned the CE mark.

March 27, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq ... Mr. Michel served as Chief Financial Officer at Vericel Corporation, a biopharmaceutical company. Mr. Michel also served as ...

Set your Gen Beta child up for financial success with 529 plans, wills, life insurance, early financial education, and investing in their future.

This news is based on a press release statement from Beta Bionics, Inc. In other recent news, Delcath Systems reported its fourth-quarter 2024 financial results, showing a revenue of $15.1 million ...

The company announced Q4 revenue of $20.4 million, a 145% increase from $8.4 million in the same quarter last year. This surpassed analyst expectations of $20.44 million. However, Beta Bionics posted ...

Falcon Finance, a next-generation synthetic dollar protocol, has officially reached its first $100 million Total Value Locked (TVL) milestone during its Closed Beta phase. The controlled rollout ...

Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various community and nonprofit organizations. She has conducted in-depth research on social and economic ...

Net sales of $20.4 million, up 145% compared to $8.4 million in the fourth quarter of 2023. Durable Medical Equipment (DME) channel net sales of $18.1 million, up 127% compared to $7.9 million in ...

A reconciliation of the non-GAAP financial measure to its most directly comparable GAAP financial measure can be found in Table E. Beta Bionics, Inc. (the "Company”) prepares and presents the ...